Medical Device

contakt world technologies corp

Contakt World

Developing Technology Driven Solutions to Public Health

HELP:CNX
CSE:HELP

Overview

COVID-19 has helped us realize the limitations of traditional healthcare systems and structures. This extends to the ways in which public health agencies communicate information with the general public, and the inaccessibility of many current contact tracing apps. With innovations to meet the demands of an increasingly digital world, public health is transforming for the better.

The global healthcare market is projected to grow to US$11.9 trillion by 2022. Given the immense importance of contact tracing and vaccine distribution management, optimizing public health through new technology should prove to be a lasting trend.

Contakt World (CSE:HELP) is a technology and media company focused on improving community health by working with public health agencies, employer establishments, healthcare providers and the public. Its digitally driven approach tackles public health programs involving pandemic response, vaccine distribution and case management.

The company’s patent-pending technology — which was built with input from public health agencies — works to bridge the gap between public health agencies and the public. They have a particular focus on making sure their information and technology reaches marginalized populations who might lack access to the latest smartphones. Its combination of robust research and development, human-centered design, next-gen data integrations and strategic health partnerships primes the company for economic growth and expansive reach.

In 2020, Contakt World’s leaders saw the urgent need for pandemic management and sought to develop innovative contact tracing and case management spanning multiple modes of communication, including apps, text, email and websites.

A year later, the company’s goal remains to become the most reliable, accessible and scalable digital public health and safety platform globally, even after the world gets a handle on COVID-19. Contakt World intends on providing lasting tech solutions that will empower public agencies with workforce and resource multipliers for more efficient contact tracing in the future.

While most companies have been releasing contact tracing apps that only work with the latest smartphones, Contakt World has partnered with MeshTek, which has hardware that works with significantly older cell phone hardware while still being accurate. As part of its commitment to serving marginalized populations, Contakt World has also dedicated a division of the company to support local health agencies with grants, stimulus funds and other grassroots initiatives to improve overall public health.

Plans for the company’s pipeline include its partnership with LogicInk for the adaption of a technology-based temporary tattoo. While the technology is used initially to monitor UV exposure, Contakt World intends to adopt it for COVID-19 testing and contact tracing, especially at high-volume venues like festivals or large events.

The company also provides an up-to-date discussion on hot-button issues surrounding COVID-19, public health, healthcare system innovation and more through its podcast. This vehicle for transparent communication often includes expert scientists, researchers and thought leaders.

Contakt World’s management team combines world-class professionals and experts in the world of public health, research, health equity and technological innovation. This dedicated team primes the company for significant growth, global outreach and success.

Contakt World’s Company Highlights

  • Contakt World is a technology and media company focused on providing digital solutions and public health programming, empowering connections between public health agencies and marginalized communities.
  • The Contakt World platform combines several communication fronts to enable innovative contact tracing and case management, including text, phone, email, websites and more.
  • The company has several key partnerships with public health agencies, NGOs and technology companies to develop accessible solutions for contact tracing. This portfolio includes iHeartRadio, LogicInk and more.
  • The company is currently working with LogicInk to adopt innovative wearable tech for contact tracing capabilities in dealing with COVID-19 and future applications at high-volume venues.
  • Contakt World has acquired Stratum Health Solutions, LLC, which operates HealthCheck by Stratum™, an encrypted wellness tracking and analytics tool with 1,000+ current customers.
Get access to more exclusive Medical Device Stock profiles here.

Recent News

Company News

Optimi Health Finalizes Partnership and Psilocybin Supply Agreement With ATMA Journey Centers

Optimi Health Corp. a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce that it has entered into an exploratory supply agreement with ATMA Journey Centers a privately held facilitator of psilocybin-assisted therapy and practitioner training services for palliative care and mental health conditions based in ...

Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce that it has entered into an exploratory supply agreement with ATMA Journey Centers ("ATMA"), a privately held facilitator of psilocybin-assisted therapy and practitioner training services for palliative care and mental health conditions based in Calgary, Alberta.

The Company has finalized an agreement which will supply psilocybin products to ATMA for future therapist initiatives and supply requirements.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Optimi Health Enters Into Psilocybin Supply Agreement With Filament Health

Optimi Health Corp. a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce that it has entered into a supply agreement with Filament Health a clinical-stage natural psychedelic drug development company. Optimi has been engaged by Filament to supply psilocybin mushrooms cultivated in Optimi’s recently ...

Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce that it has entered into a supply agreement with Filament Health ("Filament") (OTCQB:FLHLF) (NEO:FH) (FSE:7QS), a clinical-stage natural psychedelic drug development company.

Optimi has been engaged by Filament to supply psilocybin mushrooms cultivated in Optimi's recently inaugurated 20,000 square foot EU-GMP Princeton, British Columbia facility in the form of whole, dried mushroom fruiting bodies for potential drug development, testing, and analysis by Filament's research team.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Optimi Health Signs Psilocybin Supply Agreement With Halucenex Life Sciences Inc.

Optimi Health Corp. a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce that it has entered into a supply agreement with Halucenex Life Sciences Inc. a wholly owned subsidiary of Creso Pharma of Australia . Halucenex is based in Windsor, Nova Scotia and is a life sciences company focused on researching novel ...

Optimi Health Corp. ( CSE: OPTI ) (OTCQX: OPTHF) (FRA: 8BN) ("Optimi" or the "Company"), a homegrown, Canadian company producing natural, scalable, and accessible mushroom formulations for transformational human experiences, is pleased to announce that it has entered into a supply agreement with Halucenex Life Sciences Inc. ("Halucenex"), a wholly owned subsidiary of Creso Pharma of Australia (ASX: CPH). Halucenex is based in Windsor, Nova Scotia and is a life sciences company focused on researching novel psychedelic compounds, developing and licensing psychedelic compounds for the pharmaceutical and nutraceutical markets, and conducting clinical trials on the medical benefits of psychedelic medicine.

Additionally, Optimi wishes to confirm that the supply agreement pertains to the entirety of the Company's recently harvested first batch of psilocybe cubensis mushrooms at its Princeton, British Columbia facility. The mushrooms will be supplied to Halucenex in the form of whole, dried mushroom fruiting bodies.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101

Albert Labs Appoints Dr Sara Tai as Principal Investigator for upcoming RWE Study on KRN-101 Albert Labs International Corp. the "Company"), an R&D company developing mental health therapeutic medicines, is pleased to announce Dr. Sara Tai Senior Lecturer in Clinical Psychology from Manchester University, as Principal Investigator for its upcoming trial. The trial will evaluate the safety and efficacy of KRN-101, a ...

Albert Labs Appoints Dr Sara Tai as Principal Investigator for upcoming RWE Study on KRN-101

Albert Labs International Corp. ( Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), an R&D company developing mental health therapeutic medicines, is pleased to announce Dr. Sara Tai Senior Lecturer in Clinical Psychology from Manchester University, as Principal Investigator for its upcoming trial. The trial will evaluate the safety and efficacy of KRN-101, a psilocybin-based medicine, for the treatment of cancer-related distress, an indication thought to affect some 15 million patients in Europe and North America .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less